Informative new guidance on Product Design Considerations for optimising Advanced Therapy Medicinal Product (ATMP) Implementation in the NHS is now available.

The document, located on the Specialist Pharmacist Service website is authored by:

  • Owen Bain (Head of ATMP GMP Quality Control Centre for Cell Gene and Tissue Therapeutics Royal Free Hospital, London)
  • Anne Black (Regional QA Specialist Pharmacist, North East & North Cumbria)
  • David Caulfield (Assistant Director of Pharmacy – QA, The Newcastle upon Tyne Hospitals NHS Foundation Trust)

The guidance provides practical advice for the development of ATMPs to ensure their suitability for delivery in the NHS.

The document is directed towards industry and researchers in the ATMP field and encourages developers to reverse engineer to deliver products that can be successfully integrated within the hospital ecosystem.

The guidance can be accessed by using the following link: